The largest database of trusted experimental protocols

4 protocols using anti human iga fitc

1

SARS-CoV-2 Antibody Profiling Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
293F-spike–expressing cells were incubated with 100-fold diluted plasma samples for 30 min at 37°C. Cells were washed twice and stained with anti-human IgG PE, anti-human IgM Alexa Fluor 647, and anti-human IgA FITC (all from SouthernBiotech). Cells were then fixed with 4% formaldehyde solution, and fluorescence was evaluated on an LSR II (BD Biosciences).
+ Open protocol
+ Expand
2

SARS-CoV-2 Spike Protein Expression and Antibody Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 spike-expressing FreeStyle™ 293-F (RRID:CVCL_D603; Invitrogen cat. no. R79007) cells were generated by transfection with linearized plasmid (pcDNA3.1) encoding codon-optimized full-length SARS-CoV-2 spike protein (GenScript) matching the amino acid sequence having mutations E156G, D614G, P681R, T19R, T478K, L452R, D950N, and 157–158 del for Delta. Stable transfectants were single-cell sorted and selected to obtain a high-level Spike surface expressing clone (293F-Spike-Delta). 293F-Spike-Delta cells were incubated with 100 μl of 4-fold serial dilutions of plasma starting at 100-fold for 30 min at 4 °C. Cells were washed twice and stained with anti-human IgG PE, anti-human IgM Alexa Fluor 647, and anti-human IgA FITC (Southern Biotech, Birmingham, AL, USA, cat. nos. 2040-09, 2020-31, and 2050-02). Cells were then fixed with 4% formaldehyde solution (Tousimis, Rockville, MD, USA, cat. no. 1008B) and fluorescence was evaluated on a LSRII (BD Bioscience).
+ Open protocol
+ Expand
3

SARS-CoV-2 Spike Protein Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 S-expressing expi293F cells were generated by transfection with linearized plasmid (pcDNA3.1) encoding codon-optimized full-length SARS-CoV-2 S protein matching the amino acid sequence of the IL-CDC-IL1/2020 isolate (GenBank accession number MN988713). Stable transfectants were single-cell sorted and selected to obtain a high-level S surface expressing clone (293F-spike-S2A). SARS-CoV-2 S-expressing cells were incubated with 200-fold diluted plasma samples for 30 min at 37 °C. Cells were washed twice and stained with anti-human IgG PE, anti-human IgM Alexa Fluor 647, and anti-human IgA FITC (Southern Biotech). Cells were then fixed with 4% formaldehyde solution, and fluorescence was evaluated on an LSRII flow cytometer (BD Bioscience).
+ Open protocol
+ Expand
4

Bacterial IgA Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse fecal bacteria were isolated as described elsewhere 23 and were incubated for 1 hour on ice with sera, intestinal washes, or LNPC culture supernatant diluted in phosphate-buffered saline (PBS) þ protease inhibitor (cOmplete protease inhibitor, Roche, Meylan, France) to reach a concentration of 1 mg/mL of IgAs. After washings, bacteria were incubated with anti-IgA-biotin (Southern Biotech, Birmingham, AL) followed by streptavidin-APC (BD Pharmingen, Pont de Claix, France). Alternatively, ATCC strains of Escherichia coli (#8739), Enterococcus faecalis (#29212), Enterobacter cloacae (#13047) and Bacteroides vulgatus (#8482) were incubated (2.5 Â 10 7 bacteria) for 1 hour on ice with serial dilutions of human sera or human LNPC culture SN diluted in PBS þ protease inhibitor, washed, and further incubated with anti-human IgA-FITC (Southern Biotech). Bacterial suspensions then were fixed in 4% paraformaldehyde (PFA), washed, and suspended in PBS containing 2.5 mg/mL DAPI (Sigma Aldrich). Thirty thousand events were analyzed with the BD LSRII cytometer at a flow rate of 500-1500 events/s. Events that were DAPIpositive were considered as bacteria.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!